Cargando…
Tracking the timely dissemination of clinical studies. Characteristics and impact of 10 tracking variables
Background: Several meta-research studies and benchmarking activities have assessed how comprehensively and timely, academic institutions and private companies publish their clinical studies. These current “clinical trial tracking” activities differ substantially in how they sample relevant studies,...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518431/ https://www.ncbi.nlm.nih.gov/pubmed/31131084 http://dx.doi.org/10.12688/f1000research.17022.1 |
_version_ | 1783418447616540672 |
---|---|
author | Strech, Daniel Sievers, Sören Märschenz, Stefanie Riedel, Nico Wieschowski, Susanne Meerpohl, Jörg Langhof, Holger Müller-Ohlraun, Stephanie Dirnagl, Ulrich |
author_facet | Strech, Daniel Sievers, Sören Märschenz, Stefanie Riedel, Nico Wieschowski, Susanne Meerpohl, Jörg Langhof, Holger Müller-Ohlraun, Stephanie Dirnagl, Ulrich |
author_sort | Strech, Daniel |
collection | PubMed |
description | Background: Several meta-research studies and benchmarking activities have assessed how comprehensively and timely, academic institutions and private companies publish their clinical studies. These current “clinical trial tracking” activities differ substantially in how they sample relevant studies, and how they follow up on their publication. Methods: To allow informed policy and decision making on future publication assessment and benchmarking of institutions and companies, this paper outlines and discusses 10 variables that influence the tracking of timely publications. Tracking variables were initially selected by experts and by the authors through discussion. To validate the completeness of our set of variables, we conducted i) an explorative review of tracking studies and ii) an explorative tracking of registered clinical trials of three leading German university medical centres. Results: We identified the following 10 relevant variables impacting the tracking of clinical studies: 1) responsibility for clinical studies, 2) type and characteristics of clinical studies, 3) status of clinical studies, 4) source for sampling, 5) timing of registration, 6) determination of completion date, 7) timeliness of dissemination, 8) format of dissemination, 9) source for tracking, and 10) inter-rater reliability. Based on the description of these tracking variables and their influence, we discuss which variables could serve in what ways as a standard assessment of “timely publication”. Conclusions: To facilitate the tracking and consequent benchmarking of how often and how timely academic institutions and private companies publish clinical study results, we have two core recommendations. First, the improvement in the link between registration and publication, for example via institutional policies for academic institutions and private companies. Second, the comprehensive and transparent reporting of tracking studies according to the 10 variables presented in this paper. |
format | Online Article Text |
id | pubmed-6518431 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | F1000 Research Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-65184312019-05-24 Tracking the timely dissemination of clinical studies. Characteristics and impact of 10 tracking variables Strech, Daniel Sievers, Sören Märschenz, Stefanie Riedel, Nico Wieschowski, Susanne Meerpohl, Jörg Langhof, Holger Müller-Ohlraun, Stephanie Dirnagl, Ulrich F1000Res Research Note Background: Several meta-research studies and benchmarking activities have assessed how comprehensively and timely, academic institutions and private companies publish their clinical studies. These current “clinical trial tracking” activities differ substantially in how they sample relevant studies, and how they follow up on their publication. Methods: To allow informed policy and decision making on future publication assessment and benchmarking of institutions and companies, this paper outlines and discusses 10 variables that influence the tracking of timely publications. Tracking variables were initially selected by experts and by the authors through discussion. To validate the completeness of our set of variables, we conducted i) an explorative review of tracking studies and ii) an explorative tracking of registered clinical trials of three leading German university medical centres. Results: We identified the following 10 relevant variables impacting the tracking of clinical studies: 1) responsibility for clinical studies, 2) type and characteristics of clinical studies, 3) status of clinical studies, 4) source for sampling, 5) timing of registration, 6) determination of completion date, 7) timeliness of dissemination, 8) format of dissemination, 9) source for tracking, and 10) inter-rater reliability. Based on the description of these tracking variables and their influence, we discuss which variables could serve in what ways as a standard assessment of “timely publication”. Conclusions: To facilitate the tracking and consequent benchmarking of how often and how timely academic institutions and private companies publish clinical study results, we have two core recommendations. First, the improvement in the link between registration and publication, for example via institutional policies for academic institutions and private companies. Second, the comprehensive and transparent reporting of tracking studies according to the 10 variables presented in this paper. F1000 Research Limited 2018-11-29 /pmc/articles/PMC6518431/ /pubmed/31131084 http://dx.doi.org/10.12688/f1000research.17022.1 Text en Copyright: © 2018 Strech D et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Note Strech, Daniel Sievers, Sören Märschenz, Stefanie Riedel, Nico Wieschowski, Susanne Meerpohl, Jörg Langhof, Holger Müller-Ohlraun, Stephanie Dirnagl, Ulrich Tracking the timely dissemination of clinical studies. Characteristics and impact of 10 tracking variables |
title | Tracking the timely dissemination of clinical studies. Characteristics and impact of 10 tracking variables |
title_full | Tracking the timely dissemination of clinical studies. Characteristics and impact of 10 tracking variables |
title_fullStr | Tracking the timely dissemination of clinical studies. Characteristics and impact of 10 tracking variables |
title_full_unstemmed | Tracking the timely dissemination of clinical studies. Characteristics and impact of 10 tracking variables |
title_short | Tracking the timely dissemination of clinical studies. Characteristics and impact of 10 tracking variables |
title_sort | tracking the timely dissemination of clinical studies. characteristics and impact of 10 tracking variables |
topic | Research Note |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518431/ https://www.ncbi.nlm.nih.gov/pubmed/31131084 http://dx.doi.org/10.12688/f1000research.17022.1 |
work_keys_str_mv | AT strechdaniel trackingthetimelydisseminationofclinicalstudiescharacteristicsandimpactof10trackingvariables AT sieverssoren trackingthetimelydisseminationofclinicalstudiescharacteristicsandimpactof10trackingvariables AT marschenzstefanie trackingthetimelydisseminationofclinicalstudiescharacteristicsandimpactof10trackingvariables AT riedelnico trackingthetimelydisseminationofclinicalstudiescharacteristicsandimpactof10trackingvariables AT wieschowskisusanne trackingthetimelydisseminationofclinicalstudiescharacteristicsandimpactof10trackingvariables AT meerpohljorg trackingthetimelydisseminationofclinicalstudiescharacteristicsandimpactof10trackingvariables AT langhofholger trackingthetimelydisseminationofclinicalstudiescharacteristicsandimpactof10trackingvariables AT mullerohlraunstephanie trackingthetimelydisseminationofclinicalstudiescharacteristicsandimpactof10trackingvariables AT dirnaglulrich trackingthetimelydisseminationofclinicalstudiescharacteristicsandimpactof10trackingvariables |